Microneedles: A potential strategy in transdermal delivery and application in the management of psoriasis

Z Zhao, Y Chen, Y Shi - Rsc Advances, 2020 - pubs.rsc.org
The skin is an absorptive organ, targeted in the transdermal delivery system. The
microneedle method is an updated approach to deliver compounds through the skin in an …

Stigmatization in patients with psoriasis: a mini review

H Zhang, Z Yang, K Tang, Q Sun, H Jin - Frontiers in immunology, 2021 - frontiersin.org
Psoriasis is a chronic and recurrent immune-related skin disease that often causes
disfigurement and disability. Due to the visibility of lesions in patients and inadequate …

Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis

T Graier, W Salmhofer, C Jonak… - British Journal of …, 2021 - academic.oup.com
Background Drug survival rates reflect efficacy and safety and may be influenced by the
availability of alternative treatment options. Little is known about time‐dependent drug …

Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021

A Reich, C Reed, C Schuster, C Robert… - Journal of …, 2023 - Taylor & Francis
Objectives To describe the results of a structured literature review of real-world outcomes
with ixekizumab in patients with psoriasis (PsO) and/or psoriatic arthritis (PsA). Methods …

Long-term psoriasis control with guselkumab, adalimumab, secukinumab, or ixekizumab in the USA

T Fitzgerald, M Zhdanava, D Pilon, A Shah… - Dermatology and …, 2023 - Springer
Background Biologics have revolutionized the management of psoriasis, but response to
treatment varies. Loss of treatment efficacy may occur over time, requiring treatment …

[HTML][HTML] Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: a registry analysis

T Graier, W Weger, PG Sator, W Salmhofer, B Gruber… - JAAD international, 2021 - Elsevier
Background Little is known about the effectiveness and drug survival associated with
apremilast under real-world conditions. Objective To investigate the influence of patient and …

Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A …

M Gooderham, R Vender, J Crowley, HCH Hong… - Dermatology and …, 2024 - Springer
Introduction When assessing the effect of a therapy for psoriasis (PsO), it is important to
consider speed of response and cumulative response. However, responses among …

Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016–2020

E Lazaridou, G Kourlaba, S Ravanidis… - Clinical and …, 2024 - academic.oup.com
Background Drug persistence is a crucial aspect of treatment success in psoriasis.
Objectives To record real-world evidence concerning drug survival of biologic agents used …

Integration of persistence in the 5P-medicine approach for age-related chronic diseases

J Borrás-Blasco, E Ramírez-Herráiz… - … Journal for Quality in …, 2024 - academic.oup.com
Abstract 5P medicine is defined as Personalized, Predictive, Preventive, Participatory, and
Population-based. 5P medicine may be improved by including a factor that could provide …

Advances in Microneedle-Based Approaches for Skin Diseases: A Comprehensive Review of Therapeutic Applications and Future Perspectives

S Kumar, PK Sharma, R Malviya, A Alam… - Anti-Infective …, 2024 - ingentaconnect.com
Background: Psoriasis is a persistent skin condition for which only symptom management is
currently available. Topical and systemic medicines, physical therapy, and other methods …